
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas
Author(s) -
J. Douglas Thornton,
Tyler J. Varisco,
Shweta Bapat,
Callie G. Downs,
Chan Shen
Publication year - 2020
Publication title -
journal of addiction medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 42
eISSN - 1935-3227
pISSN - 1932-0620
DOI - 10.1097/adm.0000000000000756
Subject(s) - buprenorphine , medicine , pandemic , covid-19 , ambulatory , emergency medicine , medical prescription , family medicine , nursing , receptor , disease , opioid , infectious disease (medical specialty)
To measure the change in the daily number of patients receiving buprenorphine and buprenorphine prescribers during the early phase of the COVID-19 (SARS-CoV-2) pandemic in Texas.